(Q38955374)

7 September 2017

1 reference

title

Fluid biomarkers for mild traumatic brain injury and related conditions (English)

1 reference

7 September 2017

0 references

traumatic brain injury

0 references

1

Henrik Zetterberg

1 reference

7 September 2017

2

Kaj Blennow

1 reference

7 September 2017

language of work or name

English

0 references

publication date

16 September 2016

1 reference

7 September 2017

published in

Nature Reviews Neurology

1 reference

7 September 2017

volume

12

1 reference

7 September 2017

issue

10

1 reference

7 September 2017

page(s)

563-574

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2016.127

7 September 2017

exact match

0 references

cites work

Will Neuroimaging Reveal a Severe Intracranial Injury in This Adult With Minor Head Trauma?: The Rational Clinical Examination Systematic Review

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Assessment of coma and impaired consciousness. A practical scale

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Clinical Outcomes after Traumatic Brain Injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Diagnostic procedures in mild traumatic brain injury: results of the who collaborating centre task force on mild traumatic brain injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Diagnosis, prognosis, and clinical management of mild traumatic brain injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Consensus statement on concussion in sport - the Third International Conference on Concussion in Sport held in Zurich, November 2008.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Neuroimaging in Blast-Related Mild Traumatic Brain Injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Diffusion MRI: Pitfalls, literature review and future directions of research in mild traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Time interval between concussions and symptom duration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Mild traumatic brain injury and Postconcussion Syndrome: a neuropsychological perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

A review of post-concussion syndrome and psychological factors associated with concussion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

31 March 2020

Post concussion syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Examination of "postconcussion-like" symptoms in a healthy sample

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

A review of the neuro- and systemic inflammatory responses in post concussion symptoms: Introduction of the "post-inflammatory brain syndrome" PIBS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

31 March 2020

The aftermath of boxing

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Multiplicity of cerebrospinal fluid functions: New challenges in health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Structural and functional features of central nervous system lymphatic vessels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Approaching clinical proteomics: current state and future fields of application in fluid proteomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Heterophilic antibody interference in immunometric assays

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Stability of pro-gastrin-releasing peptide in serum versus plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Salivary tau species are potential biomarkers of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Ultrasensitive flow-based immunoassays using single-molecule counting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Current and future applications of mass spectrometry to the clinical laboratory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Clinical applications of MS-based protein quantification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Traumatic Brain Injury pathophysiology and treatments: early, intermediate, and late phases post-injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Biomarker-based dissection of neurodegenerative diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

F2-isoprostane and neuron-specific enolase in cerebrospinal fluid after severe traumatic brain injury in infants and children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Neuron-specific enolase as an aid to outcome prediction in head injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Predictive value of neuromarkers supported by a set of clinical criteria in patients with mild traumatic brain injury: S100B protein and neuron-specific enolase on trial: clinical article.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Blood biomarkers for brain injury in concussed professional ice hockey players.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Ubiquitin carboxyl-terminal hydrolase L1 is required for maintaining the structure and function of the neuromuscular junction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

PGP 9.5--a new marker for vertebrate neurons and neuroendocrine cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: an immunohistochemical study of 95 mesenchymal neoplasms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Current status of fluid biomarkers in mild traumatic brain injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Circulating Brain-Derived Neurotrophic Factor Has Diagnostic and Prognostic Value in Traumatic Brain Injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Plasma brain-derived neurotrophic factor levels after severe traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

31 March 2020

The many faces of tau

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Distribution of tau proteins in the normal human central and peripheral nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Neurochemical aftermath of amateur boxing.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Validity of serum tau protein levels in pediatric patients with minor head trauma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Tau protein as a serum marker of brain damage in mild traumatic brain injury: preliminary results.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

The value of serum tau protein for the diagnosis of intracranial injury in minor head trauma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Plasma tau levels in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Peripheral Total Tau in Military Personnel Who Sustain Traumatic Brain Injuries During Deployment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Serum Tau Fragments Predict Return to Play in Concussed Professional Ice Hockey Players.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Serum cleaved tau does not predict postconcussion syndrome after mild traumatic brain injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Serum Neurofilament Light in American Football Athletes Over the Course of a Season

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Spectrin breakdown products in the cerebrospinal fluid in severe head injury--preliminary observations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

A panel of neuron-enriched proteins as markers for traumatic brain injury in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Evidence That the Blood Biomarker SNTF Predicts Brain Imaging Changes and Persistent Cognitive Dysfunction in Mild TBI Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Serum SNTF Increases in Concussed Professional Ice Hockey Players and Relates to the Severity of Postconcussion Symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Expression and localization of myelin basic protein in oligodendrocytes and transfected fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Increased CSF concentrations of myelin basic protein after TBI in infants and children: absence of significant effect of therapeutic hypothermia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Slight and short-lasting increase of serum S-100B protein in extra-cranial trauma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Morphological features in human cortical brain microvessels after head injury: a three-dimensional and immunocytochemical study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Biochemical Markers for Blood-Brain Barrier Dysfunction in Acute Ischemic Stroke Correlate with Evolution and Outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

No neurochemical evidence of brain injury after blast overpressure by repeated explosions or firing heavy weapons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Occludin: one protein, many forms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

A New Panel of Blood Biomarkers for the Diagnosis of Mild Traumatic Brain Injury/Concussion in Adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Multiplex Assessment of Cytokine and Chemokine Levels in Cerebrospinal Fluid following Severe Pediatric Traumatic Brain Injury: Effects of Moderate Hypothermia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Activin a release into cerebrospinal fluid in a subset of patients with severe traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Acute CSF interleukin-6 trajectories after TBI: associations with neuroinflammation, polytrauma, and outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

In-hospital C-reactive protein predicts outcome after aneurysmal subarachnoid haemorrhage treated by endovascular coiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Multiplex assessment of serum biomarker concentrations in well-appearing children with inflicted traumatic brain injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

New Prognostic Biomarkers in Patients With Traumatic Brain Injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Cerebral extracellular chemistry and outcome following traumatic brain injury: a microdialysis study of 223 patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Serum Metabolic Profiling Reveals Altered Metabolic Pathways in Patients with Post-traumatic Cognitive Impairments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Serum amyloid A is increased in children with abusive head trauma: a gel-based proteomic analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Hepatic expression of serum amyloid A1 is induced by traumatic brain injury and modulated by telmisartan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Autoantibodies in traumatic brain injury and central nervous system trauma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Consequences of repeated blood-brain barrier disruption in football players

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Formation of microparticles in the injured brain of patients with severe isolated traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Targeted Lipid Profiling Discovers Plasma Biomarkers of Acute Brain Injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Human traumatic brain injury alters plasma microRNA levels.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Elevated serum miR-93, miR-191, and miR-499 are noninvasive biomarkers for the presence and progression of traumatic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Recovery from Mild Traumatic Brain Injury in Previously Healthy Adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Inability of S100B to predict postconcussion syndrome in children who present to the emergency department with mild traumatic brain injury: a brief report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Neuroimaging assessment of early and late neurobiological sequelae of traumatic brain injury: implications for CTE

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

PET Scanning of Brain Tau in Retired National Football League Players: Preliminary Findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Detection of brain amyloid β deposition in patients with neuropsychological impairment after traumatic brain injury: PET evaluation using Pittsburgh Compound-B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.127

Human anti-animal antibody interferences in immunological assays

31 March 2020

1 reference

12 December 2020

Cerebrospinal IL-10 concentration is elevated in non-survivors as compared to survivors after severe traumatic brain injury.

1 reference

12 December 2020

Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury

1 reference

12 December 2020

Blood-Brain Barrier Disruption Is an Early Event That May Persist for Many Years After Traumatic Brain Injury in Humans.

1 reference

12 December 2020

Mammalian occludin in epithelial cells: its expression and subcellular distribution

1 reference

12 December 2020

Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children

1 reference

12 December 2020

Oligoclonal immunoglobulins and immunoreactive myelin basic protein in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.

1 reference

12 December 2020

Diagnostic procedures in mild traumatic brain injury: results of the WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury

1 reference

12 December 2020

Pro-inflammatory and pro-apoptotic elements of the neuroinflammatory response are activated in traumatic brain injury

1 reference

12 December 2020

10.1038/NRNEUROL.2016.127

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1021674759

0 references

1 reference